Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
61.41
+0.56 (0.92%)
Aug 31, 2026, 4:00 PM EDT - Market closed
Royalty Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 811.99 | 618.7 | 929.03 | 477.01 | 1,711 | 1,541 |
Short-Term Investments | 25 | 18.8 | 58.2 | 18.3 | 25.72 | 647.87 |
Cash & Short-Term Investments | 836.99 | 637.5 | 987.23 | 495.31 | 1,736 | 2,189 |
Cash Growth | 29.74% | -35.43% | 99.31% | -71.48% | -20.67% | 6.16% |
Accounts Receivable | 920.93 | 883.7 | 810.73 | 760.84 | 727.92 | 682.66 |
Receivables | 920.93 | 883.7 | 810.73 | 760.84 | 727.92 | 682.66 |
Other Current Assets | 6.66 | 6.89 | 4.19 | 18.04 | 90.52 | 6.63 |
Total Current Assets | 1,765 | 1,528 | 1,802 | 1,274 | 2,555 | 2,878 |
Property, Plant & Equipment | - | 19.1 | - | - | - | - |
Long-Term Investments | 875.99 | 880.28 | 1,260 | 1,012 | 735.82 | 909.59 |
Goodwill | 923.54 | 924.63 | - | - | - | - |
Other Intangible Assets | - | - | 5.32 | 1.78 | 14.5 | 5.67 |
Long-Term Accounts Receivable | 16,193 | 16,208 | 15,127 | 14,089 | 13,493 | 13,718 |
Other Long-Term Assets | 62.96 | 60.19 | 28.21 | 4.74 | 15.13 | 4.14 |
Total Assets | 19,820 | 19,621 | 18,223 | 16,382 | 16,813 | 17,516 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 35.57 | 19.4 | 13.37 | 15.17 | 7.91 | 5.62 |
Accrued Expenses | 107.77 | 110.82 | 98.06 | 51.68 | 54.16 | 57.7 |
Current Portion of Long-Term Debt | 380 | 380 | 997.77 | - | 997.51 | - |
Current Portion of Leases | - | 3.16 | - | - | - | - |
Other Current Liabilities | 107.6 | 122.83 | 144.41 | 94.53 | 107.2 | 107.93 |
Total Current Liabilities | 630.93 | 636.21 | 1,254 | 161.38 | 1,167 | 171.25 |
Long-Term Debt | 8,582 | 8,571 | 6,615 | 6,135 | 6,119 | 7,096 |
Long-Term Leases | - | 16.1 | - | - | - | - |
Other Long-Term Liabilities | 821.24 | 682.61 | 12.08 | 0.9 | 2.5 | - |
Total Liabilities | 10,034 | 9,906 | 7,880 | 6,298 | 7,288 | 7,267 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 |
Additional Paid-In Capital | 4,376 | 4,123 | 4,103 | 4,011 | 3,666 | 3,508 |
Retained Earnings | 2,459 | 2,356 | 2,846 | 2,518 | 1,965 | 2,255 |
Treasury Stock | -2.72 | -2.61 | -2.66 | -2.63 | -2.81 | -2.72 |
Comprehensive Income & Other | - | - | - | - | - | 16.49 |
Total Common Equity | 6,833 | 6,477 | 6,947 | 6,526 | 5,628 | 5,777 |
Minority Interest | 2,953 | 3,238 | 3,396 | 3,558 | 3,897 | 4,472 |
Shareholders' Equity | 9,786 | 9,715 | 10,342 | 10,084 | 9,525 | 10,249 |
Total Liabilities & Equity | 19,820 | 19,621 | 18,223 | 16,382 | 16,813 | 17,516 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 8,962 | 8,970 | 7,612 | 6,135 | 7,116 | 7,096 |
Net Cash (Debt) | -8,125 | -8,333 | -6,625 | -5,640 | -5,380 | -4,907 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -14.56 | -14.76 | -11.15 | -9.35 | -12.28 | -11.83 |
Filing Date Shares Outstanding | 445.28 | 428.42 | 433.32 | 446.69 | 443.17 | 432.96 |
Total Common Shares Outstanding | 445.75 | 428.67 | 445.99 | 446.69 | 443.17 | 432.96 |
Working Capital | 1,134 | 891.88 | 548.52 | 1,113 | 1,388 | 2,707 |
Book Value Per Share | 15.33 | 15.11 | 15.58 | 14.61 | 12.70 | 13.34 |
Tangible Book Value | 5,909 | 5,552 | 6,941 | 6,525 | 5,614 | 5,771 |
Tangible Book Value Per Share | 13.26 | 12.95 | 15.56 | 14.61 | 12.67 | 13.33 |